For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts
Oneindia App Download

Health Ministry likely to withdraw use of Azithromycin in combination with HCQ

|
Google Oneindia News

New Delhi, June 12: Union Health Ministry likely to withdraw use of Azithromycin in combination with Hydroxychloroquine HCQ (antiviral drug) which is being administered to severely ill COVID19 patients.

Health Ministry likely to withdraw use of Azithromycin in combination with HCQ

However, the HCQ use for the virus patient will continue, news agency ANI quoted sources as saying.

Coronavirus: Hydroxychloroquine fails to prevent COVID-19 in a meticulous studyCoronavirus: Hydroxychloroquine fails to prevent COVID-19 in a meticulous study

According to the health ministry's current clinical management protocol for Covid, which was revised on March 31, HCQ in combination with azithromycin can be used for patients with severe disease and requiring intensive care unit (ICU) management.

Recommended Video

Rajnath Singh reviews Ladakh situation, holds meet with Cheif of defence staff | Oneindia News

The recommended dosage for HCQ is 400mg twice a day for 1 day, followed by 200mg twice a day for 4 days, and for azithromycin the ministry has recommended 500 mg once a day for 5 days.

The combination, however, is not recommended for children under the age of 12 years, pregnant and lactating women.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X